Ever Source Wealth Advisors, LLC Rigel Pharmaceuticals Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.48 Billion
- Q3 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Rigel Pharmaceuticals Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 63 shares of RIGL stock, worth $1,729. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63
Previous 63
-0.0%
Holding current value
$1,729
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RIGL
# of Institutions
9Shares Held
345KCall Options Held
0Put Options Held
0-
Telemetry Investments, L.L.C. New York, NY323KShares$8.86 Million0.76% of portfolio
-
Bergan Kdv Wealth Management, LLC10KShares$274,6000.0% of portfolio
-
Ifp Advisors, Inc1KShares$27,4600.0% of portfolio
-
Farther Finance Advisors, LLC San Francisco, CA667Shares$18,3150.0% of portfolio
-
Institutional & Family Asset Management, LLC10Shares$2740.0% of portfolio
About RIGEL PHARMACEUTICALS INC
- Ticker RIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 172,836,000
- Market Cap $4.75B
- Description
- Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...